$Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial$

Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-α1 in advanced metastatic solid tumors: a multicenter Phase II clinical trial

Abstract Purpose This multicenter Phase II clinical study assessed the efficacy and safety of hypofractionated radiotherapy (HFRT) in combination with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor (GM-CSF), and thymosin-α1 in patients with heavily treated metastatic solid tumors...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jiamin Yu, Li Yin, Wenjie Guo, Qiang Wang, Juying Liu, Lansheng Zhang, Hongxun Ye, Jianhong Xia, Youyou Xia, Jianfeng Wu, Wanwei Wang, Yanguang Yang, Dan Zong, Xia He, Lijun Wang, Hong Jiang
Format:	Article
Language:	English
Published:	Springer 2025-02-01
Series:	Cancer Immunology, Immunotherapy
Subjects:	Hypofractionated radiotherapy Immunotherapy PD-1 inhibitor Granulocyte macrophage-colony stimulating factor Thymosin-α1 Abscopal effect
Online Access:	https://doi.org/10.1007/s00262-024-03934-9
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis
by: Yong Tian, et al.
Published: (2025-06-01)

Acute toxicity outcomes in Egyptian early-stage breast cancer: ultra-hypofractionated versus hypofractionated radiotherapy
by: Ahmed Magdy, et al.
Published: (2025-05-01)

Mechanism of thymosin β10 gene in the progression of papillary thyroid carcinoma
by: MENG Jianxin, JIN Yikuan, LI Yating, ZHOU Xumin, LIAO Fangyu, YAO Fan, LI Qiang
Published: (2025-02-01)

The Value of Immature Granulocyte and Immature Granulocyte/Total Granulocyte Ratio in Predicting the Need for Surgical Treatment in Patients Diagnosed with Intestinal Ileus in the Emergency Department
by: Yunsur Çevik, et al.
Published: (2023-08-01)

Concentration-Dependent Pleiotropic Effects of Thymosin Beta4 and Cofilin on the Migratory Activity of Carcinoma Cells
by: Abdulatif Al Haj, et al.
Published: (2025-04-01)

Features of thymic endocrine function in newborns with congenital cytomegaly
by: O. M. Hyrya
Published: (2015-08-01)

Protein to biomaterials: Unraveling the antiviral and proangiogenic activities of Ac-Tβ1-17 peptide, a thymosin β4 metabolite, and its implications in peptide-scaffold preparation
by: Khandoker Asiqur Rahaman, et al.
Published: (2025-07-01)

Association of serum thymosin β4 with malnutrition-inflammation-atherosclerosis syndrome in peritoneal dialysis patients: a cross-sectional study
by: Jiakun Tian, et al.
Published: (2023-12-01)

The anti-inflammatory mechanism of thymosin β4 in a RAW 264.7 macrophage inflammation model
by: WU Tianyu, LIN Yujun, LIN Xiaoyu, ZHU Yi, YU Muxue, LIU Wangkai
Published: (2025-04-01)

Use of hypofractionated radiotherapy regimens after organ-sparing surgery for Stages I–IIA breast cancers
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma
by: Ellery Koelker-Wolfe, et al.
Published: (2025-02-01)

A prospective feasibility study on extreme hypofractionation in adjuvant radiation of breast cancer in a tertiary cancer center in India
by: Sri Sai Tejaswini Muddana, et al.
Published: (2025-07-01)

Hypofractionated radiotherapy regimens after organ-sparing surgery for stages I–IIa breast cancer
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Carcinoma buccal mucosa treated with definitive hypofractionated accelerated radiotherapy: a retrospective analysis of treatment outcomes
by: Geethu Babu, et al.
Published: (2025-07-01)

EFFICACY OF HYPOFRACTIONATED ADJUVANT RADIATION THERAPY IN PATIENTS WITH OPERABLE BREAST CANCER
by: G. V. Afonin, et al.
Published: (2018-11-01)

Thymosin β4 promotes zebrafish Mauthner axon regeneration by facilitating actin polymerization through binding to G-actin
by: Zheng Song, et al.
Published: (2024-10-01)

Case report: Short-course hypofractionated radiation therapy combined with immune checkpoint inhibitors for the treatment of advanced ovarian mucinous cystadenocarcinoma
by: Xinan Wan, et al.
Published: (2025-01-01)

Efficacy and Safety of Hypofractionated Radiotherapy With a Simultaneous Integrated Boost and With a Sequential Boost After Breast‐Conserving Surgery
by: Na Li, et al.
Published: (2025-03-01)

Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma
by: Caineng Cao, et al.
Published: (2025-05-01)

Self-delivering RNAi immunotherapeutic PH-762 silences PD-1 to generate local and abscopal antitumor efficacy
by: Benjamin Cuiffo, et al.
Published: (2024-12-01)

Hypofractionated versus conventional radiotherapy for head-and-neck cancer: A systematic review and meta-analysis
by: Arnab Roy, et al.
Published: (2025-01-01)

A Prospective Study to Assess Response and Toxicity of Hypofractionated Palliative Radiotherapy in Advanced Inoperable Oropharyngeal Carcinoma
by: Ayush Naik, et al.
Published: (2025-07-01)

Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer
by: G. V. Afonin, et al.
Published: (2018-08-01)

Case Report: Abscopal effect and long-term survival in a PD-L1 negative NSCLC patient treated with radiotherapy and immuno-chemotherapy
by: Qiang Wen, et al.
Published: (2025-08-01)

Thymosin‐β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma
by: Belamy B. Cheung, et al.
Published: (2015-08-01)

Secreted Expression of Thymosin β4 from <i>Pinctada fucata</i> in <i>Pichia pastoris</i> and Its Biological Activity
by: Peng Liu, et al.
Published: (2025-05-01)

Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs
by: Hirona Ueno, et al.
Published: (2025-02-01)

Investigation of Ki-67 and Clinical Outcome in Feline Nasal Adenocarcinoma Treated Using Hypofractionated Radiotherapy
by: Premkamon Aonta, et al.
Published: (2024-12-01)

SHORT-TERM OUTCOMES OF CHEMORADIOTHERAPY USING ACCELERATED HYPOFRACTIONATION FOR THE TREATMENT OF CANCER OF THE OROPHARYNGEAL MUCOSA
by: M. U. Radzhapova, et al.
Published: (2017-12-01)

Tumor volume changes after stereotactic, hypofractionated and conventional radiotherapy in paragangliomas of head and neck
by: Paweł J. Polanowski, et al.
Published: (2024-09-01)

Immature Granulocytes: A Novel Biomarker of Acute Pericarditis
by: Fatih Selvi, et al.
Published: (2022-01-01)

An “Older Old” Woman with Large Squamous Cell Carcinoma of the Nasal Pyramid: Excellent Response to Ultra-Hypofractionated Radiation Therapy
by: Carla Pisani, et al.
Published: (2024-08-01)

Moderately hypofractionated online adaptive radiotherapy (SWIFT-1) in cervical cancer patients: study protocol for a multi-centered, open-label, two-arm, phase III, randomized controlled study
by: Zheng Zeng, et al.
Published: (2025-07-01)

Hypofractionated image-guided radiotherapy with 70 Gy in 28 fractions for prostate cancer confined to the pelvis: a single institute experience in Taiwan
by: Hui-Lei Mu, et al.
Published: (2025-01-01)

Primary Intraoral Granulocytic Sarcoma: A Case Report and Review of Literature
by: Lamia Parveen, et al.

Characteristics of neutrophilic granulocytes of peripheral blood in patients with mechanical jaundice caused by cholangiocarcinoma
by: O. V. Smirnova, et al.
Published: (2022-03-01)

Primary granulocytic sarcoma of lip - A rare extramedullary presentation of myeloid leukemia
by: Tamojit Chaudhuri, et al.
Published: (2013-01-01)

Normal tissue complication probability modeling for late rectal bleeding after conventional or hypofractionated radiotherapy for prostate cancer
by: Christian A.M. Jongen, et al.
Published: (2025-01-01)

Verteporfin‐Mediated In Situ Nanovaccine Based on Local Conventional‐Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect
by: Zhifan Zhang, et al.
Published: (2025-05-01)

Agranulocytosis induced by metamizole and its management with granulocyte growth factor
by: Čeleketić Dušica, et al.
Published: (2005-01-01)